Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Dec
8
2016
12:30—2:00 PM
November 29, 2016
The WHO has recently debated whether to reaffirm its long-standing recommendation to deliver deworming drugs en masse to children in places with high worm prevalence. While deworming drugs are safe and cheap, a recent Cochrane review concluded there is “substantial evidence” that mass de...
WORKING PAPERS
June 16, 2014
In recent years, the interdisciplinary nature of global health has blurred the lines between medicine and social science. As medical journals publish non-experimental research articles on social policies or macro-level interventions, controversies have arisen when social scientists have criticized t...
Blog Post
September 14, 2012
The Lancet just published a letter I wrote questioning an influential study in its pages that concluded that most or all foreign aid for health goes into non-health uses. The letter follows up on concerns I expressed in this space in April 2010. Why the 2.5-year lag? Only this past January did the S...
WORKING PAPERS
October 10, 2007
In this working paper CGD research fellow David Roodman explains how the four biggest developing countries -- Brazil, Russia, India and China, a group Goldman Sachs dubbed the "BRICs" -- stack up to their rich-country counterparts on the environment component of the annual Commitment to Development ...
WORKING PAPERS
October 13, 2006
Microfinance is a widely celebrated strategy for helping poor people in the developing world. Leading microfinance institutions, including the Nobel Peace Prize-winning Grameen Bank, reach millions of clients. CGD research fellow David Roodman and Uzma Qureshi analyze why some microfinance instituti...